VAN CAEKENBERGHED.L., PATTYNS.R.In-vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinolone derivatives. Antimicrob Agents Chemother1984; 25: 518–21.
2.
FENLONC.H., CYNAMONM.H.Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellularsAntimicrob Agents Chemother1986; 29: 386–8.
3.
KRADJANW.A., BURGERR.In vivo inactivation of gentamicin by carbenicillin and ticarcillin. Arch Intern Med1980; 140: 1668–70.
4.
THOMPSONM.I., RUSSOM.E., SAXONB.J.Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother1982; 21: 268–73.
5.
T1NDULAR.J., AMBROSEP.J., HARRALSONA.F.Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring. Drug Intell Clin Pharm1983; 17: 906–8.
6.
SPRUILLW.J., MCCALLC.Y., FRANCISCOG.E.In vitro inactivation of tobramycin by cephalosporins. Am J Hosp Pharm1985; 42: 2506–9.
7.
RIFFL.J., JACKSONG.G.Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med1972; 130: 887–91.
8.
BORNERK., HOFFMANG., LOCKH.Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol1986; 5: 179–86.
